ajaduo 25mg/5mg tablet - Empagliflozin (25mg) + Linagliptin (5mg) medicine

ajaduo 25mg/5mg tablet

4.5 (10 reviews)
๐Ÿญ Lupin Ltd ๐Ÿ“ฆ Varies by brand ๐Ÿ’Š Allopathy ๐Ÿ“… Updated: Aug 21, 2026
๐Ÿ“‹ Prescription Required ๐Ÿ’Š Generic Available
Medically Reviewed
SaathiMed Expert Panel | Aug 21, 2026

What is ajaduo 25mg/5mg tablet used for?

Ajaduo (Empagliflozin + Linagliptin) is used to treat ANTI DIABETIC. It contains Empagliflozin (25mg) + Linagliptin (5mg), which Empagliflozin: inhibits SGLT2 in renal proximal tubule, reducing glucose reabsor. Always consult your doctor before use. Take as prescribed.

  • Generic Name: Empagliflozin + Linagliptin
  • Manufacturer: Lupin Ltd
  • Form: Allopathy
  • Pregnancy Category: C
  • Prescription Required: Yes
๐Ÿ’ก Did You Know? The first generic medicine was introduced in India in 1970 after the Patents Act was amended.

๐Ÿ’Š ajaduo 25mg/5mg tablet Uses & Benefits

Type 2 diabetes mellitus as adjunct to diet and exercise

Off-label uses: None established

๐Ÿ“‹ Drug Information

Generic Name(s)Empagliflozin + Linagliptin
Brand NameAjaduo
ManufacturerLupin Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI DIABETIC
Action ClassSGLT2 inhibitor + DPP-4 inhibitor
Route of AdministrationOral
StorageStore at 20-25ยฐC (68-77ยฐF), protect from moisture
Shelf LifeAs per manufacturer

๐Ÿ”ฌ Pharmacology (PK/PD)

Pharmacokinetics

AbsorptionEmpagliflozin: rapidly absorbed; Linagliptin: rapidly absorbed
DistributionEmpagliflozin: Vd ~73.8 L; Linagliptin: extensive distribution
Protein BindingEmpagliflozin: ~86%; Linagliptin: ~70-80%
MetabolismEmpagliflozin: glucuronidation (UGT2B7, UGT1A3, UGT1A8, UGT1A9); Linagliptin: minimal metabolism
Half-LifeEmpagliflozin: ~12.4 h; Linagliptin: ~113-131 h
ExcretionEmpagliflozin: feces (41%), urine (54%); Linagliptin: feces (80%), urine (5%)
BioavailabilityEmpagliflozin: ~78%; Linagliptin: ~30%
Onset of ActionEmpagliflozin: within 1-2 h; Linagliptin: within 1 h
Peak Plasma TimeEmpagliflozin: 1.5 h; Linagliptin: 1.5 h
Duration of ActionEmpagliflozin: >24 h; Linagliptin: >24 h

How It Works

Empagliflozin: inhibits SGLT2 in renal proximal tubule, reducing glucose reabsorption; Linagliptin: inhibits DPP-4, increasing incretin levels (GLP-1, GIP), enhancing insulin secretion and reducing glucagon

Mechanism Steps

1Empagliflozin inhibits SGLT2 in renal proximal tubule, reducing glucose reabsorption and increasing urinary glucose excretion.
2Linagliptin inhibits DPP-4 enzyme, preventing degradation of incretin hormones (GLP-1, GIP).
3Increased GLP-1 and GIP levels enhance glucose-dependent insulin secretion from pancreatic beta cells.

๐Ÿ’ก How to Take ajaduo 25mg/5mg tablet

Follow your doctor's prescription exactly.

โš ๏ธ Side Effects of ajaduo 25mg/5mg tablet

โœ… Common Side Effects

  • Urinary tract infections
  • Genital mycotic infections
  • Nasopharyngitis
  • Headache
  • Arthralgia

๐Ÿšจ Serious Side Effects

  • Diabetic ketoacidosis
  • Acute kidney injury
  • Hypoglycemia (when used with insulin/SU)
  • Pancreatitis
  • Hypersensitivity reactions

โš ๏ธ Rare Side Effects

  • Fournier's gangrene
  • Angioedema
  • Stevens-Johnson syndrome
  • Bullous pemphigoid

Consult your doctor if you experience any unusual symptoms.

๐Ÿ”ฌ Drug Interactions

โš ๏ธ DrugSeverityEffect
Insulin Major Increased risk of hypoglycemia
Sulfonylureas Major Increased risk of hypoglycemia
Loop diuretics Major Additive diuretic effect, risk of volume depletion
ACE inhibitors Moderate Additive blood pressure lowering
NSAIDs Moderate Reduced antihypertensive effect, risk of acute kidney injury
Corticosteroids Moderate Hyperglycemic effect may reduce efficacy

๐Ÿšจ Major Interactions

  • Insulin
  • Sulfonylureas
  • Loop diuretics

โšก Moderate Interactions

  • ACE inhibitors
  • ARBs
  • NSAIDs
  • Corticosteroids

โ„น๏ธ Minor Interactions

  • Beta-blockers
  • Calcium channel blockers

๐Ÿฝ๏ธ Food Interactions

Food delays absorption of empagliflozin but not clinically significant; linagliptin unaffected

๐Ÿท Alcohol Interaction

May increase risk of hypoglycemia

๐Ÿ›ก๏ธ Safety & Warnings

๐Ÿšซ Contraindications

Severe renal impairment (eGFR <30), end-stage renal disease, dialysis, history of serious hypersensitivity reaction, diabetic ketoacidosis

๐Ÿ“Š Monitoring Parameters

Blood glucose, HbA1c, renal function (eGFR), electrolytes, blood pressure, signs of volume depletion

๐Ÿคฑ Lactation Safety

Not recommended; unknown if excreted in human milk

๐Ÿ’Š Overdose Management

Supportive care; monitor blood glucose, electrolytes, and renal function; hemodialysis unlikely to remove empagliflozin

โฐ Missed Dose

Take as soon as remembered unless almost time for next dose; do not double dose

๐Ÿ‘จโ€โš•๏ธ Reviewed by Expert

SaathiMed Expert Panel

MD, PhD - Pharmacology

Last reviewed on: Aug 21, 2026

๐Ÿ”— View Profile

โญ User Reviews

Regular Customer Jul 10, 2026

Good quality medicine. Satisfied with the outcome.

Regular Customer Jul 10, 2026

Good quality medicine. Satisfied with the outcome.

Certified Buyer Jul 10, 2026

Effective and reliable. Worked as expected.

Verified User Jul 10, 2026

Helpful and effective medicine as per my experience. Always consult a doctor.

Regular Customer Jul 10, 2026

Found this to be a helpful product. Good results.

๐Ÿ˜Š Was this information helpful?

Browse Medicines A-Z

Search our extensive medical database alphabetically.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory